JP Morgan Initiates Coverage On Conmed with Overweight Rating, Announces $136 Price Target

JP Morgan initiates coverage on Conmed (NASDAQ:CNMD) with a Overweight rating and a $136 price target.

Benzinga · 11/12/2019 11:22

JP Morgan initiates coverage on Conmed (NASDAQ:CNMD) with a Overweight rating and a $136 price target.